Business

Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln

Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln

Enorama Pharma AbNovember 19, 20254
Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln

About this update from Enorama Pharma Ab

Enorama Pharma AB OMXSTO:ERMA:Q3 NET SALES -193 (7,481) THOUSAND SEKQ3 OPERATING PROFIT -12,339 (-4,476) THOUSAND SEK

View stock analysis, news, and events for Enorama Pharma Ab